Athira Pharma (ATHA)
(Delayed Data from NSDQ)
$2.01 USD
-0.03 (-1.47%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $2.00 -0.01 (-0.50%) 6:02 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.80 | 0.00% |
Earnings Summary
For their last quarter, Athira Pharma (ATHA) reported earnings of -$0.71 per share, beating the Zacks Consensus Estimate of $-0.96 per share. This reflects a positive earnings surprise of 26.04%. Look out for ATHA's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.80 per share, reflecting a year-over-year decrease of 9.59%.
Earnings History
Price & Consensus
Zacks News for ATHA
Is Arcutis Biotherapeutics (ARQT) Outperforming Other Medical Stocks This Year?
ATHA: What are Zacks experts saying now?
Zacks Private Portfolio Services